drugset / Trial / NCT00717262
Phase 1 Placebo Controlled Study of the Safety, Activity and Pharmacokinetics of HQK-1001 in Healthy Subjects
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to evaluate the safety, activity and pharmacokinetics of a new investigational drug (HQK-1001) in healthy human volunteers. This study will also evaluate if there are differences in these parameters when HQK-1001 is administered in a fed versus a fasted state.
Timeline
- Start
- 2008-05
- Primary completion
- 2008-08
- Completion
- 2008-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | HQK-1001 | Unknown | 5 mg/kg | Oral |
| Subject | HQK-1001 | Unknown | 10 mg/kg | Oral |
| Subject | HQK-1001 | Unknown | 15 mg/kg | Oral |
Indications
No indication recorded.